Belgian dialysis market demand set to increase
This article was originally published in Clinica
The ageing of the population in Belgium and the increased number of type 2 diabetic patients is expected to result in increasing demands for haemodialysis and peritoneal dialysis services. In turn, this will mean increased costs for the Belgian government.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.